Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Assumes the role of chief executive with immediate effect and will be stationed at Stelis HQ in Bengaluru, India.
August 6, 2021
By: Tim Wright
Editor-in-Chief, Contract Pharma
Stelis Biopharma, a vertically integrated biopharma and vaccines company and the biotech arm of Strides Pharma Science Limited, has appointed Mark W. Womack as the new CEO. He is also the managing director designate and will be inducted to the board later subject to necessary statutory clearances and processes. As the new CEO and managing director, Womack will provide leadership to drive an aggressive growth and profitability strategy for Stelis in its business streams that include global contract development and manufacturing organization (CDMO) services and the development of the company’s biosimilars pipeline, and integrated vaccines play. He will be responsible for the company’s overall strategy and provide the necessary direction and leadership to R&D, manufacturing, business development, and commercial operations. “We are delighted to onboard Mark as the new CEO of Stelis,” said Arun Kumar, founder, Strides Group. “Stelis stands on the cusp of a transition to become a globally recognized biopharmaceutical company while targeting significant growth in the coming years. Mark’s strong background in commercial leadership, rich management consulting experience, and network within the biotech CDMO space make him exceptionally well suited to drive this transition for Stelis. We are confident that together Mark and his leadership team will take Stelis through the next level of growth, profitability and industry-leading reputation.” Before joining Stelis, Womack was the chief business officer for AGC Biologics. In his role at AGC, he led the organization to nearly a three-times increase in new sales in just two years and drove the acquisition of most of the world’s top large pharma companies into their portfolio. Before that, leveraging his management consulting background, Mark led the global integration of three former CDMOs that were merged to create AGC Biologics. Womack has served over 25 years as a management consulting industry leader and C-level client advisor, leading large-scale business transformations and guiding many of the world’s renowned companies to achieve record highs in revenue and profit. During this time, he served as the Chief Operating Officer for two international management consulting companies. Before joining the management consulting industry, Womack led a succession of US Navy units, including serving as a combat center leader on a destroyer class ship. He will be based at the company’s corporate headquarter in Bengaluru, India.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !